Welcome to our dedicated page for Cabot SEC filings (Ticker: CBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cabot Corporation (NYSE: CBT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a global specialty chemicals and performance materials company, Cabot uses its SEC filings to report financial performance, segment results for Reinforcement Materials and Performance Chemicals, risk factors, sustainability information and corporate governance matters.
Investors can review Cabot’s annual reports on Form 10-K and quarterly reports on Form 10-Q to see detailed discussions of net sales, earnings, segment EBIT, regional volume trends and cash flows, along with commentary on demand conditions in the Americas, Europe, the Middle East and Africa, and Asia Pacific. These filings also describe key product areas such as reinforcing carbons, specialty carbons, battery materials, fumed metal oxides, inkjet colorants, masterbatches and conductive compounds, engineered elastomer composites and aerogel.
Cabot’s current reports on Form 8-K disclose material events, including the release of quarterly operating results, agreements such as the planned acquisition of Mexico Carbon Manufacturing S.A. de C.V. from Bridgestone Corporation, supply arrangements for battery materials and changes in board composition. Form 8-K filings also reference earnings press releases that provide non-GAAP measures like Adjusted EPS, Total Segment EBIT and Adjusted EBITDA, along with reconciliations to GAAP metrics.
Through Stock Titan, users can track Cabot’s real-time filing activity from EDGAR and use AI-powered summaries to interpret complex documents. These summaries highlight key points from lengthy 10-K and 10-Q filings, explain the significance of non-GAAP measures and clarify disclosures about segment performance, sustainability initiatives and capital allocation. The filings page also helps users locate proxy materials and insider transaction reports on Form 4, which provide additional context on executive and director roles, equity-based compensation and share ownership changes.
By consolidating Cabot’s SEC filings with AI-generated insights, this page supports users who want to understand how the company reports on its reinforcing carbons and performance chemicals businesses, evaluates risks and opportunities, and communicates with regulators and investors.
Cabot Corporation reported lower results for the quarter ended December 31, 2025, its first quarter of fiscal 2026. Net sales and other operating revenues fell to $849 million from $955 million, mainly due to lower volumes and less favorable pricing and product mix in both Reinforcement Materials and Performance Chemicals.
Net income attributable to Cabot dropped to $73 million, or $1.37 per diluted share, from $93 million, or $1.67 per diluted share. Reinforcement Materials EBIT declined to $102 million from $130 million on weaker tire-related demand and competitive pressure in Asia, while Performance Chemicals EBIT increased to $48 million from $45 million on better product mix and cost controls.
Operating cash flow was strong at $126 million, supporting capital spending of $69 million, share repurchases of $52 million, and common dividends of $24 million. Cabot ended the quarter with $230 million in cash and $1.2 billion of available borrowing capacity. The company also initiated a restructuring in Performance Chemicals and later closed a ~$70 million acquisition of a carbon black plant in Mexico.
Cabot Corporation filed a current report to let investors know it has released operating results for its fiscal quarter ended December 31, 2025. The company did this by issuing a press release on February 3, 2026, which is included as Exhibit 99.1.
The 8-K itself mainly serves as a formal notice that these quarterly results are now available through the attached press release, rather than presenting detailed financial figures directly in the report.
Cabot Corporation has issued its 2026 proxy statement for a fully virtual Annual Meeting of Stockholders on March 12, 2026 at 4:00 p.m. Eastern Time. Stockholders of record at the close of business on January 14, 2026, when 52,221,604 shares of common stock were outstanding, may vote.
Investors are asked to elect three directors for terms expiring in 2029, approve on an advisory basis the company’s executive compensation, and ratify Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending September 30, 2026. The Board also describes its ESG-focused oversight structure, including a Safety, Health, Environment & Sustainability Committee and 2030 sustainability goals. Executive pay is positioned as strongly performance-based, with most CEO and senior executive compensation delivered through at-risk annual incentives and long-term equity awards tied to adjusted EPS and return on net assets.
Cabot Corporation reported upcoming changes to its board structure around the 2026 Annual Meeting of Stockholders. The current terms of directors Juan Enriquez and William C. Kirby will end at that meeting. The board has nominated existing director Thierry Vanlancker, whose current term runs to the 2028 annual meeting, to stand for election at the 2026 Annual Meeting for a new term extending to the 2029 annual meeting.
To enable this change, on January 8, 2026, Mr. Vanlancker submitted a conditional resignation effective immediately before the 2026 Annual Meeting, contingent on his reappointment to a new term that will then expire at the 2026 Annual Meeting. His resignation and reappointment are described as being solely to rebalance the three board classes so they are approximately equal in size.
Cabot Corporation director Juan Enriquez reported an acquisition of company stock through a compensation-related transaction. On January 8, 2026, he acquired 486 shares of Cabot common stock at a price of $0 per share, reflecting equity granted rather than an open-market purchase. The filing notes that these shares have been deferred under Cabot's Non-Employee Directors' Deferral Plan, meaning the director has chosen to defer receipt of the shares according to that plan's terms. Following this transaction, Enriquez beneficially owns 41,526 Cabot common shares, held directly.
Cabot Corporation director Raffiq Nathoo reported acquiring 2,298 shares of Cabot common stock on January 8, 2026. The filing shows the shares were credited at a price of $0 per share and were deferred under Cabot's Non-Employee Directors' Deferral Plan, meaning they reflect deferred director compensation rather than an open-market purchase. Following this transaction, Nathoo beneficially owned 9,266 Cabot shares, held directly.
Cabot Corporation director Doug G. Del Grosso reported acquiring 2,298 shares of Cabot common stock on January 8, 2026. The shares were recorded at a price of $0.00 per share, indicating they were received without cash consideration, such as through an equity award or similar arrangement. Following this transaction, Del Grosso directly holds 15,079 shares of Cabot common stock. The filing indicates the transaction was made by a single reporting person in his capacity as a director.
Cabot Corporation director Thierry Vanlancker reported an acquisition of company common stock through a compensation-related deferral. On January 8, 2026, he acquired 2,298 shares of Cabot common stock at a stated price of $0 per share, classified as an acquisition transaction. After this transaction, he beneficially owned 4,902 Cabot shares in total, held directly.
According to the footnote, these shares have been deferred under Cabot's Non-Employee Directors' Deferral Plan, meaning they arise from the director compensation program rather than an open‑market purchase. The filing indicates this report is made by a single reporting person in his capacity as a director of Cabot Corporation.
Cabot Corporation director reports stock award under deferral plan. Director Michelle Elizabeth Williams acquired 2,298 shares of Cabot Corporation common stock on January 8, 2026, reported as an award at a price of $0 per share. Following this award, she beneficially owned 6,776 shares of Cabot common stock in total.
The filing notes that these shares have been deferred under Cabot's Non-Employee Directors' Deferral Plan, meaning the award is subject to the terms of that plan rather than delivered as immediately unrestricted shares.